Spots Global Cancer Trial Database for stage i oropharyngeal squamous cell carcinoma

Every month we try and update this database with for stage i oropharyngeal squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer	NCT01748942	Dysphagia Pain Stage I Orophar... Stage II Oropha... Stage III Oroph...	Dexamethasone Dexamethasone Placebo Quality-of-Life... Questionnaire A... Transoral Robot...	18 Years -	OHSU Knight Cancer Institute
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer	NCT02827838	Human Papilloma... Stage I Oral Ca... Stage I Orophar... Stage II Oral C... Stage II Oropha... Stage III Oral ... Stage III Oroph... Stage IVA Oral ... Stage IVA Oroph... Stage IVB Oral ... Stage IVB Oroph... Stage IVC Oroph...	Durvalumab Laboratory Biom... Therapeutic Con...	18 Years -	Wake Forest University Health Sciences
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer	NCT01932697	Human Papilloma... Stage I Orophar... Stage II Oropha... Stage III Oroph... Stage IVA Oroph... Stage IVB Oroph...	Docetaxel Hyperfractionat... Intensity-Modul... Laboratory Biom... Quality-of-Life...	18 Years -	Mayo Clinic
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer	NCT02827838	Human Papilloma... Stage I Oral Ca... Stage I Orophar... Stage II Oral C... Stage II Oropha... Stage III Oral ... Stage III Oroph... Stage IVA Oral ... Stage IVA Oroph... Stage IVB Oral ... Stage IVB Oroph... Stage IVC Oroph...	Durvalumab Laboratory Biom... Therapeutic Con...	18 Years -	Wake Forest University Health Sciences
Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery	NCT02007200	Recurrent Hypop... Recurrent Laryn... Recurrent Laryn... Recurrent Lip a... Recurrent Oral ... Recurrent Oroph... Stage I Hypopha... Stage I Larynge... Stage I Larynge... Stage I Lip and... Stage I Oral Ca... Stage I Orophar... Stage II Hypoph... Stage II Laryng... Stage II Laryng... Stage II Lip an... Stage II Oral C... Stage II Oropha... Stage III Hypop... Stage III Laryn... Stage III Laryn... Stage III Lip a... Stage III Oral ... Stage III Oroph... Stage IV Hypoph... Stage IVA Laryn... Stage IVA Laryn... Stage IVA Lip a... Stage IVA Oral ... Stage IVA Oroph... Tongue Carcinom...	Laboratory Biom... Soy Isoflavones Survey Administ...	19 Years - 79 Years	National Cancer Institute (NCI)
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer	NCT02827838	Human Papilloma... Stage I Oral Ca... Stage I Orophar... Stage II Oral C... Stage II Oropha... Stage III Oral ... Stage III Oroph... Stage IVA Oral ... Stage IVA Oroph... Stage IVB Oral ... Stage IVB Oroph... Stage IVC Oroph...	Durvalumab Laboratory Biom... Therapeutic Con...	18 Years -	Wake Forest University Health Sciences

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: